Immunomic Therapeutics, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 3
- DOL-certified
- 100%
- Median offered wage
- $172,864
Rockville, MD NAICS: 541714
Immunomic Therapeutics, Inc., by the LCA numbers
U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming Immunomic Therapeutics, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
How many H-1B petitions has USCIS approved for Immunomic Therapeutics, Inc.?
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 3 H-1B petitions naming Immunomic Therapeutics, Inc. through FY2023, and approved nearly every one of them: 100% approved (3 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
Immunomic Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
3 52221st of 122824 higher than 70,603 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Headquartered in Rockville, MD. Methodology.
LCA filing shape · Immunomic Therapeutics, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $166,860–$175,866 .
Title concentration
- Director, Financial Planning and Analysis 3 · 100% · $172,864
Worksite counties
- MONTGOMERY, MD 1 · 100%
Local thin filer
Immunomic Therapeutics, Inc. (Rockville, MD) has 3 disclosed LCA s with worksites in a single state on this extract. Top title: Director, Financial Planning and Analysis. Small-N percentages swing hard on one withdrawn filing.
Recent LCA Filings
Latest H-1B labor condition applications filed by Immunomic Therapeutics, Inc.
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| Director, Financial Planning and Analysis | Rockville, MD | $175,866 | Certified | FY2026 |
| Director, Financial Planning and Analysis | Rockville, MD | $175,866 | Certified | FY2026 |
| Director, Financial Planning and Analysis | Rockville, MD | $166,860 | Certified | FY2023 |
Nationwide peers near Immunomic Therapeutics, Inc.'s 3-LCA band
Cross-state DOL neighbors for Immunomic Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MD.
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($172,864 here).
What People Ask
How many H-1B LCA filings list Immunomic Therapeutics, Inc.?
Immunomic Therapeutics, Inc. is listed in 3 DOL Labor Condition Application filings covering 3 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Where does Immunomic Therapeutics, Inc. rank among H-1B employer filers by volume?
Among 122,824 employer filers in the DOL disclosure extract, Immunomic Therapeutics, Inc. ranks #40445 by total LCA filing count (3 filings). 70,603 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
How often are Immunomic Therapeutics, Inc.'s LCAs certified by the Labor Department?
Immunomic Therapeutics, Inc. has a 100% DOL certification rate, with 3 out of 3 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
How much does Immunomic Therapeutics, Inc. offer according to its H-1B filings?
The average offered wage listed in Immunomic Therapeutics, Inc.'s LCAs is $172,864. Listed wages range from $166,860 to $175,866 and are not verified actual compensation.
What roles does Immunomic Therapeutics, Inc. file the most H-1B LCAs for?
The top job titles in Immunomic Therapeutics, Inc.'s LCA filing records include Director, Financial Planning and Analysis. The most common listed title is Director, Financial Planning and Analysis with 3 LCA filings at an average listed offered wage of $172,864. This does not establish actual job openings, hiring, or approved petitions.
Where is Immunomic Therapeutics, Inc. located?
Immunomic Therapeutics, Inc. is headquartered in Rockville, MD.
Is Immunomic Therapeutics, Inc. H-1B dependent?
No, Immunomic Therapeutics, Inc. is not classified as H-1B dependent.
What is the year-over-year trend in Immunomic Therapeutics, Inc.'s LCA filings?
Immunomic Therapeutics, Inc. is listed in 1 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $166,860 to $175,866. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
Read with Immunomic Therapeutics, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Immunomic Therapeutics, Inc.); CERT-SOFT · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Immunomic Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Immunomic Therapeutics, Inc.); CERT-LOCK · WAGE-PAR vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 3 LCAs (Δ 0 heavier vs Immunomic Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's TRACE-BOOK · CERT-LOCK · WAGE-ELITE.
MD pole at 30,440 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Immunomic Therapeutics, Inc.'s TRACE-BOOK.
Open the MD state board after the ABS peers. Immunomic Therapeutics, Inc. stamps TRACE-BOOK · CERT-LOCK inside that worksite mix.
Immunomic Therapeutics, Inc.'s WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Immunomic Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Immunomic Therapeutics, Inc. filed 3 LCAs in the indexed extract (100% certified in-file). That volume ranks higher than 67% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MD rank on LCA filing volume this vintage. MD filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.